[1]
RADKE, R. and K. JAIN, N. 2022. ENHANCEMENT OF SOLUBILITY AND BIOAVAILABILITY OF BCS CLASS-II AMBRISENTAN: IN VITRO, IN VIVO AND EX VIVO ANALYSIS. International Journal of Applied Pharmaceutics. 14, 1 (Jan. 2022), 67–74. DOI:https://doi.org/10.22159/ijap.2022v14i1.43347.